Bookmark and Share
(4-(4-Phenoxyphenyl)-2H-1,2,3-triazol-2-yl)(pyrrolidin-1-yl)methanone (CID 56593028) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(3)
 
 
Inactive(8)
 
 
Top Targets:
PAF-AH p II(2)
 
 
Abhydrolase 2(1)
 
 
Hydrolase 4(1)
 
 
Lipase 3(1)
 
 
PLN02442(1)
 
 
BioAssay Types:
Confirmatory(4)
 
 
 
BioActivity Types:
IC50(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 4    Data Row: 11   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103913571]
IC50 0.002Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) IC50 [AID504494, Type: confirmatory]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
2
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_1, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
3
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_2, Type: other]Apeh protein, partial [Mus musculus] [gi:20072022]
View
4
[SID103913571]
48Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511_1, Type: confirmatory]
View
5
[SID103913571]
50Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511_2, Type: confirmatory]
View
6
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513, Type: other]
View
7
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511, Type: confirmatory]
View
8
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of overexpressed DAGLb in vitro; triazole urea library [AID602303, Type: other]sn1-specific diacylglycerol lipase beta [Mus musculus] [gi:31559956]
View
9
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_3, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
10
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_4, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
11
[SID103913571]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_5, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View